FDA·Medicines·February 11, 2026

Sun Pharmaceutical recalls Diclofenac Sodium 3% topical gel because it is slightly thinner than required

A test found the gel's viscosity (how thick it is) came out slightly lower than the allowed limit, so the 100 g tubes did not meet the required specifications.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7
Hazard
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Units
N/A
Where sold
US Nationwide.
FDA classification
Class II · Ongoing
Classified by FDA
February 23, 2026
Recall started
January 27, 2026
FDA enforcement report
February 11, 2026
Identifiers
  • Codes: Lot # AD92721, Exp Date: 3/31/2027.
  • FDA recall number: D-0342-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7
Reason for recall
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Classification
Class II (Ongoing)
Distribution
US Nationwide.
Quantity
N/A

Related recalls